1 Resources


<!-- THEME DEBUG -->
<!-- THEME HOOK: 'field' -->
<!-- FILE NAME SUGGESTIONS:
   ▪️ field--node--title--pin.html.twig
   ✅ field--node--title.html.twig
   ▪️ field--node--pin.html.twig
   ▪️ field--title.html.twig
   ▪️ field--string.html.twig
   ▪️ field.html.twig
-->
<!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->
Availability, cost and affordability of essential  medicines for chronic respiratory diseases in low-income and middle-income countries: a cross sectional study
<!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

BMJ, Thorax

Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross sectional study

Article

07 May 2024

Contemporary data on the availability, cost and affordability of essential medicines for chronic respiratory diseases (CRDs) across low-income and middle-income countries (LMICs) are missing, despite most people with CRDs living in LMICs. Cross-sectional data for seven CRD medicines in pharmacies, healthcare facilities and central medicine stores were collected from 60 LMICs in 2022–2023. Medici...

Access